Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci - PubMed (original) (raw)
Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci
M L Watson et al. J Exp Med. 1992.
Abstract
In MRL mice, the mostly recessive lpr mutation results in both the accumulation of CD4-, CD8-, CD3+ T cells in lymphoid tissue and many features of generalized autoimmune disease, including immune complex glomerulonephritis. To positionally clone the lpr mutation and analyze the effects of background genes, backcross offspring were examined from the cross: (MRL/MpJ-lpr x CAST/Ei)F1 x MRL/MpJ-lpr. The lpr gene was found to be closely linked to a mouse chromosome 19 marker defined by a variation of a Fas gene restriction fragment. Our results identified differences in RNA expression and differences in the genomic organization of the Fas gene between normal and lpr mice, and confirm the recent report that a mutation in the Fas apoptosis gene is the lpr mutation. However, our results also indicate that the Fas gene is expressed in spleen cells from normal mice, and spleen and lymph node cells from mice with a second mutation at the lpr locus (lprcg). Together these results suggest that altered Fas transcription results in the failure of lymphocytes to undergo programmed cell death and may lead to an altered immune cell repertoire. This mechanism may explain certain central and peripheral defects in tolerance that are present in autoimmune disease. The current study also demonstrates the profound effect of background genes on the degree of nephritis, lymphadenopathy, and anti-DNA antibody production. Of major note, our studies suggest the identification of chromosomal positions for genes that modify nephritis. Analysis of the backcross mice for markers covering most of the mouse genome suggests that over 50% of the variance in renal disease is attributable to quantitative trait loci on mouse chromosomes 7 and 12. Moreover, this study provides a model for dissecting the complex genetic interactions that result in manifestations of autoimmune disease.
Similar articles
- Autoimmunity in mice bearing lprcg: a novel mutant gene.
Kimura M, Matsuzawa A. Kimura M, et al. Int Rev Immunol. 1994;11(3):193-210. doi: 10.3109/08830189409061727. Int Rev Immunol. 1994. PMID: 7930845 Review. - Distinctive expression of lprcg in the heterozygous state on different genetic backgrounds.
Ogata Y, Kimura M, Shimada K, Wakabayashi T, Onoda H, Katagiri T, Matsuzawa A. Ogata Y, et al. Cell Immunol. 1993 Apr 15;148(1):91-102. doi: 10.1006/cimm.1993.1093. Cell Immunol. 1993. PMID: 8495493 - A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse.
Matsuzawa A, Moriyama T, Kaneko T, Tanaka M, Kimura M, Ikeda H, Katagiri T. Matsuzawa A, et al. J Exp Med. 1990 Feb 1;171(2):519-31. doi: 10.1084/jem.171.2.519. J Exp Med. 1990. PMID: 2406366 Free PMC article. - Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ. Gu L, et al. J Immunol. 1998 Dec 15;161(12):6999-7006. J Immunol. 1998. PMID: 9862736 - Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis.
Nose M, Terada M, Nishihara M, Kamogawa J, Miyazaki T, Mori S, Nishimura M, Wang Y, Kamoto T, Hiai H. Nose M, et al. Int J Cardiol. 1998 Oct 1;66 Suppl 1:S37-41; discussion S43. doi: 10.1016/s0167-5273(98)00146-6. Int J Cardiol. 1998. PMID: 9951801 Review.
Cited by
- PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis.
Yamaguchi J, Isnard P, Robil N, de la Grange P, Hoguin C, Schmitt A, Hummel A, Megret J, Goudin N, Luka M, Ménager MM, Masson C, Zarhrate M, Bôle-Feysot C, Janiszewska M, Polyak K, Dairou J, Baldassari S, Baulac S, Broissand C, Legendre C, Terzi F, Canaud G. Yamaguchi J, et al. J Clin Invest. 2024 Jun 6;134(15):e176402. doi: 10.1172/JCI176402. J Clin Invest. 2024. PMID: 38842935 Free PMC article. - A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus.
Daems C, Sékulic M, Vulsteke V, van Loo G, D'Hooge R, Callaerts-Végh Z, Callaerts P. Daems C, et al. Brain Behav Immun Health. 2019 Dec 14;2:100018. doi: 10.1016/j.bbih.2019.100018. eCollection 2020 Feb. Brain Behav Immun Health. 2019. PMID: 38377433 Free PMC article. - Panax notoginseng saponins reverse steroid resistance in lupus nephritis: Involvement of the suppression of exosomal P-gp levels from lymphocytes to glomerular endothelial cells.
Pan F, Lu Y. Pan F, et al. Biochem Biophys Rep. 2023 Nov 9;36:101568. doi: 10.1016/j.bbrep.2023.101568. eCollection 2023 Dec. Biochem Biophys Rep. 2023. PMID: 38024866 Free PMC article. - Osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting breast cancer secondary metastasis.
Wu Y, Ai H, Xi Y, Tan J, Qu Y, Xu J, Luo F, Dou C. Wu Y, et al. Cell Rep Med. 2023 Sep 19;4(9):101165. doi: 10.1016/j.xcrm.2023.101165. Epub 2023 Aug 21. Cell Rep Med. 2023. PMID: 37607544 Free PMC article. - Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model.
Baek WY, Lee SM, Lee SW, Son IO, Choi S, Suh CH. Baek WY, et al. J Rheum Dis. 2021 Jul 1;28(3):133-142. doi: 10.4078/jrd.2021.28.3.133. J Rheum Dis. 2021. PMID: 37475994 Free PMC article.
References
- J Immunol. 1992 May 1;148(9):2817-25 - PubMed
- Nature. 1992 Mar 26;356(6367):314-7 - PubMed
- Nature. 1991 Jun 13;351(6327):542-7 - PubMed
- Biochem Genet. 1991 Aug;29(7-8):325-35 - PubMed
- J Immunol. 1991 May 1;146(9):3012-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous